The Association Between Radioiodine Refractory in Papillary Thyroid Carcinoma, Sodium/Iodide Symporter Expression, and BRAF V600E Mutation.
Tauangtham AnekpuritanangMaythad UatayaApichaya ClaimonNatthawadee LaokulrathWarut PongsapichPaveena PithuksurachaiPublished in: OncoTargets and therapy (2021)
Papillary thyroid carcinomas with BRAF V600E mutation were more likely to be negative for NIS expression. BRAF V600E mutation and NIS expressions cannot be used to predict radioiodine sensitivity.